Loading
OT
Ocera Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Byrnes Michael, was filed 28 Mar 2017.
Ocera Therapeutics, Inc.: what insiders have been doing
Ocera Therapeutics, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Ocera Therapeutics, Inc. has published a filing in the past twelve months. The most recent one dates from 13 December 2017.
Our records for Ocera Therapeutics, Inc. go back to 2016, with 8 purchases and 3 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
50
Thresholds
n/a
Buy Volume
€99,774
8 ops. · all time
Sell Volume
€13,275
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Revenue542.9k
Net income-24M-4416.3% margin
Last declaration on 13 December 2017
Declarations50 total
988,285 sharesCommon StockSEC:0000904454-17-000718:0
1,857,036 sharesCommon StockSEC:0000904454-17-000722:0
15,731 sharesCommon StockSEC:0000904454-17-000725:0
7,333 sharesCommon StockSEC:0000904454-17-000720:0
47,963 sharesCommon StockSEC:0000904454-17-000727:0
13,000 shares@ US$1.527.6% of flowCommon StockSEC:0000899243-17-028418:0
150,000 shares@ US$1.5287.8% of flowCommon StockSEC:0000899243-17-028418:1
12,500 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-17-028423:0
230,000 shares@ US$1.5265.8% of flowCommon StockSEC:0000899243-17-028424:0
70,000 shares@ US$1.5220.0% of flowCommon StockSEC:0000899243-17-028424:1
12,500 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-17-028420:0
344,719 shares@ US$1.5293.4% of flowCommon StockSEC:0000899243-17-028412:0
11,969 shares@ US$1.523.2% of flowCommon StockSEC:0000899243-17-028412:1
12,500 shares@ US$1.523.4% of flowCommon StockSEC:0000899243-17-028412:2
12,500 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-17-028414:0
5,000 shares@ US$1.5228.6% of flowCommon StockSEC:0000899243-17-028411:0
12,500 shares@ US$1.5271.4% of flowCommon StockSEC:0000899243-17-028411:1
12,500 shares@ US$1.52100.0% of flowCommon StockSEC:0000899243-17-028413:0
2,500 shares@ US$1.521.2% of flowCommon StockSEC:0000899243-17-028422:0
200,000 shares@ US$1.5296.6% of flowCommon StockSEC:0000899243-17-028422:1
12,500 shares0Common StockSEC:0001274644-17-000057:0
12,500 shares0Common StockSEC:0001274644-17-000061:0
12,500 shares0Common StockSEC:0001274644-17-000060:0
12,500 shares0Common StockSEC:0001274644-17-000058:0
12,500 shares0Common StockSEC:0001274644-17-000059:0
25 of 50 declarations
About Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for liver diseases. It is listed on the NASDAQ under the ticker OCRX.
